Related Experiment Videos
Experience with a totally implantable venous device in children
American Journal of Diseases of Children (1960)
|January 1, 1986
Summary
Totally implantable central venous catheters offer convenient, long-term venous access for pediatric cancer patients. However, potential complications like extravasation, migration, thrombosis, and sepsis require careful consideration.
Area of Science:
- Pediatric Oncology
- Vascular Surgery
- Medical Devices
Background:
- Prolonged central venous access is crucial for pediatric cancer treatment.
- Totally implantable central venous catheters (TICVCs) provide a solution for long-term venous access.
- Assessing the safety and efficacy of TICVCs in pediatric oncology is essential.
Purpose of the Study:
- To evaluate the use of TICVCs in children undergoing cancer treatment.
- To identify the complications associated with TICVCs in this patient population.
- To weigh the benefits against the risks of using TICVCs for prolonged venous access.
Main Methods:
- Utilized TICVCs with reservoirs in 15 pediatric patients.
- Monitored catheter dwell times ranging from 28 to 581 days.
- Documented all major and minor complications encountered during the study period.
Main Results:
- A cumulative experience of 4,094 days with TICVCs was achieved.
- Major complications included extravasation (1), catheter migration (1), catheter thrombosis (2), and catheter-related sepsis (2).
- Devices were generally well-accepted by patients, parents, and healthcare providers.
Conclusions:
- TICVCs offer significant advantages such as ease of care and improved quality of life for pediatric cancer patients.
- Despite potential complications, TICVCs remain a viable option for prolonged central venous access.
- Careful patient selection and monitoring are crucial to mitigate risks associated with TICVCs.